Overview

Post Marketing Surveillance Study to Observe Safety and Efficacy of Inlyta in South Korea

Status:
Not yet recruiting
Trial end date:
0000-00-00
Target enrollment:
Participant gender:
Summary
The objective of this study is to monitor the usage of INLYTA® in real practice, including the adverse events associated with INLYTA®.
Phase:
N/A
Details
Lead Sponsor:
Pfizer
Treatments:
Axitinib